泓博医药(301230.SZ)：前三季度净利润3474.96万元 同比增加127.96%
Pharma Resources (Shanghai) Pharma Resources (Shanghai) (SZ:301230) Ge Long Hui A P P·2025-10-29 10:05

Core Viewpoint - Hongbo Pharmaceutical (301230.SZ) reported significant growth in revenue and net profit for the first three quarters of 2025, indicating strong operational performance and potential investment opportunities [1] Financial Performance - The company achieved a revenue of 514 million yuan, representing a year-on-year increase of 31.43% [1] - The net profit attributable to shareholders reached 34.75 million yuan, marking a year-on-year increase of 127.96% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 27.71 million yuan, reflecting a substantial year-on-year increase of 353.43% [1] - Basic earnings per share stood at 0.2489 yuan [1]